University of Delaware

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Delaware sits in the top decile of US sponsors by registered trial count (#231 of 15,742 sponsors by registered trial count).

106 total trials 24 currently recruiting 72 completed later-stage tilt top decile by trial count

University of Delaware: 106 sponsored US clinical trials, 24 recruiting.

University of Delaware sponsors 106 registered US clinical trials on ClinicalTrials.gov, 24 of them currently recruiting, and 72 completed. 8 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Parkinson Disease, with 4 trials.

Top-decile sponsor footprint

University of Delaware ranks in the top decile of sponsors by registered trial count (#231 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 71/100

72 of 78 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

106 total, page 3 of 3

COMPLETED Phase 1

Mental Health Services for Toddlers in Foster Care

NCT01261806
COMPLETED NA

Effectiveness of a Parent Training Program for Parents of Children Adopted Internationally

NCT00816621
COMPLETED Phase 4

The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure

NCT00624559
COMPLETED NA

Long-term Use of Proton Pump Inhibitors May Cause Vitamin B12 Deficiency in the Institutionalized Elderly

NCT00843453
COMPLETED Phase 1

Mental Health Services for Foster and Adopted Children

NCT00056303
COMPLETED NA

Wedged Orthoses and Knee Osteoarthritis

NCT00420147
← Previous Page 3 of 3

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 3 1
Phase 4 7

Therapeutic Areas

Parkinson Disease 4
Cardiovascular Risk Factor 3
Aging 3
Stroke 3
Salt-Sensitivity of Blood Pressure 2
Diet, Healthy 2
Estrogen 2
Mild Cognitive Impairment 2
Blood Pressure 2
Hypertension 2

Where University of Delaware enrollment is open (later-stage tilt)

24 recruiting of 106 indexed (23% open); 72 completed (68%).

Phase mix: 8 late (III/IV) vs 3 early (I/II) (later-stage heavy).

Top condition: Parkinson Disease (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Delaware: open-pipeline peers nationwide

Peers matched on 106 registered trials and 23% open enrollment, not the therapeutic-area sidebar.

University of Delaware sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 5%10%15%20%25% Total trials Recruiting share University of DelawareAugusta UniversityCorewell Health EastGeisinger ClinicSt. Louis UniversityOhio State University Comprehensive Cancer CenterUniversity of VirginiaUniversity of Kansas Medical CenterVeterans Medical Research Foundation
University of Delaware sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Delaware sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 106 trials (± recruiting share)

Sponsors near 23% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Delaware page

106 registered trials is a research-attention snapshot, not an endorsement of University of Delaware or any single study.

  • 24 of University of Delaware's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Parkinson Disease is the condition University of Delaware studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parkinson Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Delaware pipeline card: 106 registered trials from official public datasets.Report a data error.